Singapore-based SGInnovate has a unique multi-stakeholder business model focused on identifying and funding Deep Tech startups. CEO Dr Lim Jui now plans to increase the group’s activity in advanced manufacturing and “wetware” — drugs and diagnostics — as firms increasingly are able to revert to pre-COVID business plans.
Bot MD has raised US$5 million in Series A round led by Monk's Hill Ventures. Other investors in the round include SeaX Ventures, XA Network and SGInnovate, healthcare industry veterans Lu Yoh-Chie and Jean-Luc Butel, as well as Silicon Valley notable, Steve Blank.
See-Mode Technologies, a MedTech startup based in Singapore and Australia that seeks to empower clinicians to better predict stroke, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its debut product, Augmented Vascular Analysis (AVA), a world-first medical Artificial Intelligence (AI) software for automated analysis and reporting of vascular ultrasound scans.
See-Mode Technologies, announced today it has raised a US$7 million Series A funding, led by Mass Mutual Ventures Southeast Asia (MMV SEA). Other participants in the round include existing investors Blackbird Ventures, Cocoon Capital, Entrepreneur First, and SGInnovate, besides a group of angels.
A former finalist in The Irish Times Innovation Awards, HealthBeacon has raised €12 million to date with backers including SGInnovate, a private company owned by the Singapore government. Other investors include Manatt Health, BVP, Elkstone Partners and Bill McCabe’s Oyster Capital.
NDR Medical Technology has raised S$8 million in a Series A funding round led by MicroPort Scientific, a Chinese medical device developer and manufacturer, NDR said on Monday. Other investors in the round include existing investor SGInnovate, and new investor Kava Ventures, a venture partnership founded by owners of medical tech distributor Transmedic.